RN7SL401P

Across TCGA pan-cancer cohorts, RN7SL401P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RN7SL401P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RN7SL401P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL401P expression acts as an unfavorable survival marker.

OV, CHOL, and STAD are the cancer types where RN7SL401P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	III,IV	0.225	0.536	.001	42	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
STAD	DFS	Tertile	All	0.527	0.735	.034	9	view →
UCEC	OS	Tertile	All	0.844	0.928	.028	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RN7SL401P–OV (DFS)

Open the OV breakdown →